Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mata

Showing results (471-480 of 493) with videos related to

Pageof 50
Sort By:
The Journal of Molecular Diagnostics : JMD|January 4, 2026
Phenotypic POLE variant classification identifies patients who may have favorable prognosis and benefit from immunotherapyRachel B Keller-Evans, Zoe Fleischmann, Smruthy Sivakumar, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 15, 2022
Activating IGF1R hotspot non-frameshift insertions define a novel, potentially targetable molecular subtype of adenoid cystic carcinomaMatthew Margolis, Tyler Janovitz, Jason Laird, et al.
Nature Communications|January 9, 2024
Multiple redox switches of the SARS-CoV-2 main protease in vitro provide opportunities for drug designLisa-Marie Funk, Gereon Poschmann, Fabian Rabe von Pappenheim, et al.
Biodiversity Data Journal|June 21, 2024
The InBIO Barcoding Initiative Database: DNA barcodes of Portuguese mothsSónia Ferreira, Martin F V Corley, João Nunes, et al.
The American Journal of Surgical Pathology|February 19, 2024
Pan-cancer Genomic Analysis of AXL Mutations Reveals a Novel, Recurrent, Functionally Activating AXL W451C Alteration Specific to MyxofibrosarcomaErik A Williams, Isabella Vegas, Fardous F El-Senduny, et al.
Acta Neuropathologica Communications|November 10, 2020
Genetic and epigenetic landscape of IDH-wildtype glioblastomas with FGFR3-TACC3 fusionsDouglas A Mata, Jamal K Benhamida, Andrew L Lin, et al.
The Oncologist|June 9, 2021
Clinicopathologic and Genomic Landscape of Breast Carcinoma Brain MetastasesRichard S P Huang, James Haberberger, Kimberly McGregor, et al.
Histopathology|February 29, 2024
Liquid biopsy-based circulating tumour (ct)DNA analysis of a spectrum of myeloid and lymphoid malignancies yields clinically actionable resultsDouglas A Mata, Jessica K Lee, Vignesh Shanmugam, et al.
NPJ Precision Oncology|September 14, 2024
Pan-tumor validation of a NGS fraction-based MSI analysis as a predictor of response to PembrolizumabDouglas I Lin, Julia C F Quintanilha, Natalie Danziger, et al.
The American Journal of Surgical Pathology|January 16, 2022
HPV51-associated Leiomyosarcoma: A Novel Class of TP53/RB1-Wildtype Tumor With Predilection for the Female Lower Reproductive TractErik A Williams, Meagan Montesion, Vadim Lincoln, et al.
Pageof 50

Showing results (471-480 of 493) with videos related to

Sort By:
Pageof 50
The Journal of Molecular Diagnostics : JMD|January 4, 2026
Phenotypic POLE variant classification identifies patients who may have favorable prognosis and benefit from immunotherapyRachel B Keller-Evans, Zoe Fleischmann, Smruthy Sivakumar, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 15, 2022
Activating IGF1R hotspot non-frameshift insertions define a novel, potentially targetable molecular subtype of adenoid cystic carcinomaMatthew Margolis, Tyler Janovitz, Jason Laird, et al.
Nature Communications|January 9, 2024
Multiple redox switches of the SARS-CoV-2 main protease in vitro provide opportunities for drug designLisa-Marie Funk, Gereon Poschmann, Fabian Rabe von Pappenheim, et al.
Biodiversity Data Journal|June 21, 2024
The InBIO Barcoding Initiative Database: DNA barcodes of Portuguese mothsSónia Ferreira, Martin F V Corley, João Nunes, et al.
The American Journal of Surgical Pathology|February 19, 2024
Pan-cancer Genomic Analysis of AXL Mutations Reveals a Novel, Recurrent, Functionally Activating AXL W451C Alteration Specific to MyxofibrosarcomaErik A Williams, Isabella Vegas, Fardous F El-Senduny, et al.
Acta Neuropathologica Communications|November 10, 2020
Genetic and epigenetic landscape of IDH-wildtype glioblastomas with FGFR3-TACC3 fusionsDouglas A Mata, Jamal K Benhamida, Andrew L Lin, et al.
The Oncologist|June 9, 2021
Clinicopathologic and Genomic Landscape of Breast Carcinoma Brain MetastasesRichard S P Huang, James Haberberger, Kimberly McGregor, et al.
Histopathology|February 29, 2024
Liquid biopsy-based circulating tumour (ct)DNA analysis of a spectrum of myeloid and lymphoid malignancies yields clinically actionable resultsDouglas A Mata, Jessica K Lee, Vignesh Shanmugam, et al.
NPJ Precision Oncology|September 14, 2024
Pan-tumor validation of a NGS fraction-based MSI analysis as a predictor of response to PembrolizumabDouglas I Lin, Julia C F Quintanilha, Natalie Danziger, et al.
The American Journal of Surgical Pathology|January 16, 2022
HPV51-associated Leiomyosarcoma: A Novel Class of TP53/RB1-Wildtype Tumor With Predilection for the Female Lower Reproductive TractErik A Williams, Meagan Montesion, Vadim Lincoln, et al.
Pageof 50